The effect of HemoHIM supplement for the prevention of ventilator associated pneumonia

Phase 3

• Conditions: Ventilator associated pneumonia.; Ventilator associated pneumonia; J95.851

• Registration Number: IRCT20150221021159N6
• Lead Sponsor: Esfahan University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 April 2021

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Gaining informed consent
Adult patients undergoing mechanical ventilation for more than 48 hours

Exclusion Criteria

Diagnosis of acute respiratory distress syndrome or pneumonia at intensive care unit (ICU) admission
Existence of immunodeficiency and leukopenia

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Incidence of ventilator associated pneumonia. Timepoint: Evaluation of the occurrence of ventilator associated pneumonia daily, during 14 days after study recruitment. Method of measurement: Calculate the clinical pulmonary infection score (CPIS) table.